These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 25264278

  • 21. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin.
    Dong P, Zhang Y, Gu J, Wu W, Li M, Yang J, Zhang L, Lu J, Mu J, Chen L, Li S, Wang J, Liu Y.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1373-80. PubMed ID: 21855619
    [Abstract] [Full Text] [Related]

  • 22. Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer.
    Ji L, Li H, Gao P, Shang G, Zhang DD, Zhang N, Jiang T.
    PLoS One; 2013 Oct 11; 8(5):e63404. PubMed ID: 23667609
    [Abstract] [Full Text] [Related]

  • 23. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
    Song YN, Guo XL, Zheng BB, Liu XY, Dong X, Yu LG, Cheng YN.
    Toxicol In Vitro; 2011 Jun 11; 25(4):937-43. PubMed ID: 21402141
    [Abstract] [Full Text] [Related]

  • 24. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells.
    Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH.
    Phytomedicine; 2010 Jan 11; 17(1):47-54. PubMed ID: 19577445
    [Abstract] [Full Text] [Related]

  • 25. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z, Sun X, Feng Y, Wang Y, Zhang L, Wang Y, Fang Z, Azami NLB, Sun M, Li Q.
    Phytomedicine; 2021 Feb 11; 82():153414. PubMed ID: 33461143
    [Abstract] [Full Text] [Related]

  • 26. Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway.
    Gao AM, Ke ZP, Shi F, Sun GC, Chen H.
    Chem Biol Interact; 2013 Oct 25; 206(1):100-8. PubMed ID: 23994249
    [Abstract] [Full Text] [Related]

  • 27. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
    Li Y, Guo Y, Feng Z, Bergan R, Li B, Qin Y, Zhao L, Zhang Z, Shi M.
    Nutr Cancer; 2019 Oct 25; 71(6):1007-1018. PubMed ID: 31032633
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, Lou HX.
    Eur J Pharmacol; 2008 Apr 14; 584(1):66-71. PubMed ID: 18304528
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
    Wang L, Meng Q, Wang C, Liu Q, Peng J, Huo X, Sun H, Ma X, Liu K.
    J Nat Prod; 2013 May 24; 76(5):909-14. PubMed ID: 23621869
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
    Zhang L, Wang Z, Khishignyam T, Chen T, Zhou C, Zhang Z, Jin M, Wang R, Qiu Y, Kong D.
    Biomed Pharmacother; 2018 Jul 24; 103():1069-1078. PubMed ID: 29710665
    [Abstract] [Full Text] [Related]

  • 37. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY, Kim DH, Kim EH, Na HK, Kim NJ, Suh YG, Surh YJ.
    Chem Res Toxicol; 2011 Aug 15; 24(8):1231-41. PubMed ID: 21728338
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
    Peterson BG, Tan KW, Osa-Andrews B, Iram SH.
    Pharmacol Res; 2017 May 15; 119():313-326. PubMed ID: 28258008
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.